Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-11-17 Purchase | 2023-11-21 12:19 pm | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 25,000 | $1.09 | $27,250 | 79,000 (Direct) | View |
2023-11-16 Purchase | 2023-11-20 10:07 am | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 50,000 | $0.9399 | $46,995 | 54,000 (Direct) | View |
2023-03-31 Purchase | 2023-04-03 4:15 pm | Beyond Air Inc. | XAIR | Forbes William P Director | 5,000 | $6.67 | $33,350 | 14,855 (Direct) | View |
2023-03-17 Purchase | 2023-03-20 4:05 pm | Beyond Air Inc. | XAIR | Forbes William P Director | 5,000 | $6.46 | $32,300 | 9,855 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-10-19 Exercise | 2024-10-21 3:53 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 3,874 | $0 | 153,489 (Direct) | View |
2024-07-19 Exercise | 2024-07-22 09:44 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 3,875 | $0 | 153,489 (Direct) | View |
2024-06-06 Exercise | 2024-06-07 09:34 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 12,500 | $0 | 132,874 (Direct) | View |
2024-04-19 Exercise | 2024-04-19 5:02 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 3,874 | $0 | 140,989 (Direct) | View |
2024-03-20 Option Award | 2024-03-21 9:01 pm | N/A 2034-03-20 | Beyond Air Inc. | XAIR | Forbes William P Director | 45,000 | $0 | 45,000 (Direct) | View |
2024-01-19 Option Award | 2024-01-19 9:01 pm | N/A 2034-01-19 | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 433,924 | $0 | 433,924 (Direct) | View |
Ownership | 2023-06-12 4:41 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 0 | $0 | 1,254,000 (Direct) | View |
2023-03-29 Option Award | 2023-03-31 4:15 pm | N/A 2033-03-28 | Beyond Air Inc. | XAIR | Forbes William P Director | 40,000 | $0 | 40,000 (Direct) | View |
2022-06-29 Option Award | 2022-07-01 4:49 pm | 2022-06-29 2031-02-16 | Trevi Therapeutics Inc. | TRVI | Forbes William P Chief Development Officer | 48,000 | $0 | 48,000 (Direct) | View |
2022-02-11 Option Award(A) | 2022-07-01 4:43 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | Forbes William P Chief Development Officer | 137,500 | $0 | 137,500 (Direct) | View |
2022-03-03 Option Award | 2022-03-07 08:33 am | N/A 2032-03-02 | Beyond Air Inc. | XAIR | Forbes William P Director | 30,000 | $0 | 30,000 (Direct) | View |
2022-02-11 Option Award | 2022-02-15 4:00 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | Forbes William P Chief Development Officer | 137,500 | $0 | 137,500 (Direct) | View |
2021-03-04 Option Award | 2021-03-08 8:02 pm | N/A 2031-03-03 | Beyond Air Inc. | XAIR | Forbes William P Director | 25,000 | $0 | 25,000 (Direct) | View |
2021-02-01 Option Award | 2021-02-03 4:20 pm | N/A 2031-01-31 | Trevi Therapeutics Inc. | TRVI | Forbes William P Chief Development Officer | 200,000 | $0 | 200,000 (Direct) | View |